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ABSTRACT 
 
Aerosols of depleted uranium oxides, formed upon high-energy impact of shells on hard targets 
during military operations, are able to disperse, reach the alveolar region of the lungs and be 
absorbed and distributed throughout various parts of the body. The absorbed particles are subjected 
to clearance in the upper respiratory tract, distribution to other body districts, dissolution, and 
excretion. While the soluble forms of uranium are known to deliver a small dose of radiation to the 
body due to their homogeneous distribution and the low specific activity of 
238
U, ceramic particles 
exhibit a low dissolution rate and irradiate a limited volume of tissue for a long time with   
particles with energy 4.267 MeV. The extent of the irradiated tissues depends on the radius of the 
particles and the total intake of uranium oxides. For the measured intake of U3O8 of a war veteran 
(        ) the number of particles ranges from          to          for sizes of     
      . Modeling the distribution of the particles between two compartments of the body, the 
averaged dose absorbed in 20 years by tissues surrounding the particles and within the range of the 
  particles varies from        to         for lungs and        to        for the lymph nodes, 
respectively. Correspondingly, due to the clearance and redistribution, the mass irradiated by 
       particles falls in 20 years from        to 0.94 g in the lungs and grows from zero to 1.0 
mg in the lymph nodes. The estimated rate of formation of hydroxyl radicals upon radiolysis of 
water in the lungs and lymph nodes is              per cell after one year. 
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INTRODUCTION 
 
Depleted uranium (DU) is characterized by a reduced content of the isotope 
235
U with respect to 
natural uranium and is obtained as a by-product of the enrichment process of natural and 
reprocessed uranium. It is used in military combat in various projectiles because it is readily 
available, pyrophoric, and it has a unique armor-piercing capability due to its high density. Upon 
high-energy impact, the shells of DU heat up, fragment and oxidize into a mixture of uranium 
oxides with various oxidation states
(1)
, usually dominated by U3O8. The dispersed ceramic particles 
of DU oxides with sizes of the order of      are able to reach the alveolar region of the lungs upon 
inhalation. Whether the biological effects following the exposure to aerosols of DU oxides are 
responsible for the complex syndrome affecting the military and civilian populations around combat 
areas is still a matter of controversy
(2,3,4,5)
. The long half-life of the isotope 
238
U (   ⁄        
      ) makes its specific activity relatively low, and it is easy to show that the dose absorbed by 
the people exposed to DU aerosols is a small fraction of the background radiation. However, it is 
difficult to reconcile the low estimate of the radiation dose delivered to the whole body by the 
intake of depleted uranium
(6,7,8,9)
 and the reports of the complex array of symptoms affecting war 
veterans and civilian populations, however anecdotal. 
As a contribution to this issue, this work points out the small portion of an idealized body affected 
by the radiation delivered by a mass    of U3O8 (molecular mass               
  , density 
              
  ) in the form of particles of initial radius   , containing exclusively the 
isotope 
238
U. It will be shown that depleted uranium particles are able to deliver a much higher 
radiation dose with respect to the soluble forms of uranium, albeit to a small mass of tissue. 
The actual distribution of 
238
U following an instantaneous respiratory intake of ceramic particles of 
U3O8 was modeled by Valdés
(10)
, who described how the species containing 
238
U distribute among 
lungs, lymph nodes, kidneys, bones, blood, and other tissues and are eventually excreted via the 
urine. The model developed in this work computes the amount of radiation absorbed by the tissue 
surrounding the particles in the two compartments of the body where the ceramic oxide particles 
mostly reside, i.e. the lungs and the lymph nodes. To partition the cumulative dose affecting all the 
different body compartments, one would have to solve a complete set of differential equations 
representing all fluxes among the compartments. 
The calculation of the absorbed dose does not include the contribution from the beta decay of 
daughter radionuclides 
234
Th (   ⁄         ,            
      ,             ) and 
234m
Pa (   ⁄          ,            
      ,           ), in secular equilibrium with 238U 
(                  ,   4.267 MeV) through the first three steps of the decay chain of 238U 
 
    
 
→      
  
→       
  
→       
 
The contribution of the gamma emissions, the possible presence of 
236
U, heavier actinides, and the 
residual 
235
U in the particles are also neglected. 
 
 
RESULTS AND DISCUSSION 
 
We begin by taking into consideration the           intake of 238U of a Persian Gulf War I veteran 
estimated by Valdés
(10)
 from the analysis of a urine sample. This value is bracketed by the estimated 
       intake in the neighborhood of a burning tank hit by a 120 mm DU projectile and the 
corresponding intake of        at a distance of 200 m from the impact site(11). At the breathing rate 
of           in a contaminated area with a DU air concentration of        , the assumed 
exposure of           would be reached in        . The corresponding mass of U3O8 is    
         . As we shall see, the mass of 238U in the body is time-dependent because of the excretion 
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mechanisms acting after the exposure, and we indicate the instantaneous value of the mass with  . 
The number of 
238
U nuclei at any given time is thus 
 
    
 
 
             
 
(3 being the number of 
238
U nuclei in each molecule of U3O8) and, at    , we have    
           , corresponding to the activity              . The average distance between   
sources of   particles distributed in a body mass   is 
 
  (
  
   
)
  ⁄
           
 
If the uranium is in a soluble form, like a uranyl salt, we would have     , and the distribution in 
the body of both the 
238
U and its   radiation may be considered homogeneous over the whole mass. 
In fact, for         , the average distance between 
238
U nuclei would be        , smaller than 
the range   of the   particles themselves,          (ASTAR database)(12). 
The power transferred to the body by the decay of 
238
U is                
    , where 
 
                    
                                  
 
is the energy per nuclear disintegration. The corresponding delivered dose rate   is   divided by the 
mass of the irradiated tissue, with units of a specific power,       . If the energy in Eq. (3) is 
multiplied by the corresponding weight factor for   particles (20), we obtain the effective dose rate 
in       . Neglecting the effect of the relatively short biological half-life of soluble forms of 
uranium in the human body (    ), we obtain that the dose delivered to the body (        ) by 
the homogeneous distribution is                  , a small fraction of the average background 
radiation dose of                 . This approximate result corresponds to      
             for one year, in agreement with the reported value of the effective absorbed dose 
following a hypothetical single acute inhalation of       (                )(7). The 
corresponding dose conversion factor is                     , about one half of the accurate 
value                      (11). 
On the other hand, if the particles are in the form of spheres of U3O8 with initial radius   , their 
number    would be related to the mass by 
 
          
 
 
   
            
 
The number of particles    (listed in Table 1) for initial radius               is        
  
          
 . In this case,      and the average distance between the   sources according to 
Eq. (2) is                       , 2-3 orders of magnitude larger than the range of the   
particles. Consequently, the distribution of 
238
U in the body may not be considered homogeneous, 
each particle delivering its radiation only to a sphere of radius            and mass    
     ⁄    
 . Since the range of the   particles emitted by 238U in uranium (       ) exceeds the 
size of the particles, we do not correct for self-absorption. In this case the absorbed energy is not 
distributed to the whole body, but limited by the range of the   particles to the time-dependent mass 
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where we have identified the body density with the density of water   . Typical values of    are a 
fraction of a gram. The irradiated energy will be averaged over the limited portions of the organs 
directly affected by the   radiation. This approach leads to considerably higher doses with respect 
to the standard methods, which assess doses by averaging over the whole tissue mass. The initial 
dose rate delivered by    particles thus is 
 
    
     
 
  
    
           
 
independent of the number of the particles since the ratio     ⁄  depends only on    and the 
density of the material, according to Eq. (4). The range of the initial dose rate for        
       is                        
  , to be compared to                   for the 
homogeneous system. Since the dissolved fraction of U3O8 gives a negligible contribution to the 
radiation dose, we only keep track of the uranium still present in the body as undissolved particles. 
The particles are assumed to distribute in two compartments: the lungs, where the particles are 
subjected to both dissolution and clearance, and the interstitium and lymph nodes, identified by 
Valdés
(10)
 as the main repository of undissolved particles, where the particles are only subjected to 
dissolution. The transport of the particles from the lungs into the lymph nodes exhibits the rate 
coefficient          
      , while the clearance towards the mucociliary escalator takes place 
with the rate coefficient          
       (10), both processes being mediated by the alveolar 
macrophages. 
Since the particles dissolve over time regardless of their location, their number is actually time-
dependent. To compute the amount of undissolved U3O8 taking into account the dissolution rate of 
U3O8 particles, we follow the process as described by Chazel et al., 
(7)
 that is the sum of a rapidly 
dissolving fraction   with rate coefficient    and a slowly dissolving fraction     with rate 
coefficient   . We thus have two sets of rate coefficients: the transport coefficients    and   , 
governing the transfer of particles, and the dissolution coefficients    and   , that remove uranium 
from the particles. The relevant differential equations for transport and dissolution (two for the 
rapidly-dissolving fractions,    and   , and two for the slowly-dissolving fractions,    and   , 
where   and   represent the mass of U3O8 in lungs and lymph nodes, respectively) are 
 
 ̇                          
 
with solution 
 
    ⁄                     
 
where 
 
                  
           
 
     
                      
      
 
For the rapidly and slowly-dissolving fraction in the lymph nodes (  ) 
 
 ̇                      
 
with solution 
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    ⁄  
  
     
                        
 
where         . Plots of     ⁄  and     ⁄  versus time are shown in Fig. 1. The values of 
the rapidly dissolving fraction and of the dissolution coefficients are       ,          
  , and 
         
      , indicating a biological half-life of the slow-dissolving fraction of        . 
For comparison, the rate coefficient for the dissolution of U3O8 particles in alveolar macrophages 
given by Poncy et al. 
(13)
 is             . Thus the total mass         in the form of 
particles is 
 
   ⁄  
      
     
                   
 
exhibiting a mean life for the slowly-dissolving fraction approximately equal to        
   
          . Defining 
 
   
     
        
          
       
        
  
 
the corresponding cleared and dissolved fractions of the initial intake are           and 
          ⁄                     , respectively. The excretion of the uranium content 
of the body after dissolution is almost exclusively urinary, and its distribution was modeled by 
Wrenn et al. 
(14)
. According to the model presented here, the total normalized dissolution rate is 
       
  (                   ), starting at     
       at     and rapidly dropping to 
           after 110 days. 
The irradiated mass was computed for each compartment according to Eq. (5) with the time-
dependent number of particles given by 
 
 ̇                        
 
 ̇                  
 
with solutions 
 
    ⁄               
 
    ⁄  
  
     
                 
 
and 
 
   ⁄  
      
     
            
 
The quantities     ⁄  and     ⁄  are shown in Fig. 2, and the corresponding masses    and    
are obtained multiplying by the mass of tissue    irradiated by a single particle. The result 
reproduces Valdés’ observation that a fraction ~10% of the initial intake is permanently sequestered 
in the lymph nodes. The values of    and   reported in Tables 2 and 3 depend on   , and we can 
see that the amount of irradiated mass differ considerably in the two compartments. 
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The time-dependent dose rates delivered to the two compartments (     ) according to Eqs. (8) 
and (10) are 
 
    ⁄                   
 
with the specific dose rate at     defined by Eq. (6). The dose rate delivered to the lungs and 
lymph nodes is the sum of two exponentials, decreasing in time from the initial value   , as shown 
in Fig. 3. The dose rate at     is reported in Table 1 for specific values of the initial radius of the 
particles, along with the number of irradiated cells assuming a cell number density         
              . With this value of the cell number density, we obtain the constant ratio 1.56 
cells/particle. The initial content    of 
238
U in the body and the size of the particles determine the 
extent of the irradiated mass    in each compartment, the radiation being delivered to only a small 
amount of tissue for a prolonged period of time. Both in the lungs and the lymph nodes the full 
      dose from particles of size      is absorbed by     . 
The total dose is independent of the number of particles (as is   ) and of the transport coefficients, 
and is obtained by integration of the dose rate as 
 
   ∫       
 
 
            
 
affording the expression 
 
    ⁄    
           
                     
 
for each compartment. In the absence of both transport and dissolution we would have     ⁄   . 
The plot of Eq. (19) in Fig. 4 shows that after      the dose reaches        , reaching         after 
     . An average quantity that takes into account the extent of the irradiated tissue in each 
compartment would be 
 
     ∫  
  
 
  
 
 
            
 
in the assumption that the dissolved forms of 
238
U are rapidly excreted and only the surviving 
particles contribute significantly to the total radiation dose. The averaged dose defined by Eq. (20) 
correctly depends on both the transport and dissolution rate coefficients, and the total dose    is 
partitioned in the two compartments, since             . 
The averaged dose could also be defined with respect to the initial number of particles   , affording 
 
     ∫  
  
  
  
 
 
                      
 
and 
 
     ∫  
  
  
  
 
 
   [  (
  
  
 
  
  
)  
  
     
     (
  
  
 
  
  
)]            
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However, in this case the sum           would not amount to    as defined by Eq. (19) 
and the definition making use of the weight     ⁄  would give an unrealistically small averaged 
dose in both compartments for a large clearance rate (large   ), since 
 
   
  → 
  
  
    
  → 
              
 
   
  → 
  
  
    
  → 
  
     
(            )     
 
while 
 
   
  → 
  
 
    
  → 
        
         
    
           
   
 
and 
 
   
  → 
  
 
    
  → 
  (   
         )
    
           
   
 
giving    
  → 
       . For this reason we choose to compute the average doses with Eq. (20). 
In this work, the dose rate   , the dose   , and the averaged dose      are all computed for an 
irradiated mass fixed in space. Since the particles of U3O8 are being transported by the macrophages 
while they irradiate, the computed values are accurate only in the assumption that the actual time 
spent by the particles migrating inside the macrophages is negligible compared to the effective 
transport mean time   
  . Values of   ,   , and      are reported as functions of    and   in 
Tables 4 and 5-7 for the lungs and lymph node compartments. From the time-dependent plots of 
     and      shown in Fig. 4, we can see that the dose delivered to the lungs by      
particles rises sharply and levels off after        at a maximum of         , while the 
corresponding averaged specific dose delivered to the lymph nodes reaches         and is still 
increasing even       after the exposure. The averaged doses delivered to the two compartments are 
comparable, with the dose to the first compartment, being the location of the initial intake, 
dominating for the first      . The absorbed dose (albeit by a small mass of tissue, as made clear by 
the data in Tables 2-3) may be divided by the total initial mass of 
238
U3O8 to obtain,       after the 
intake of      particles, the dose conversion factors      and             for the lungs and 
lymph nodes, respectively. For the homogeneous system the corresponding value reported by Bem 
and Bou-Rabee
(11)
 is                . The wide separation between these two conversion 
factors summarizes the difference between the homogeneous and the non-homogeneous system. 
The           intake of DU might seem negligible compared both to the average content in the 
human body of       and the annual intake of        by ingestion of food and water(6), but if the 
radionuclide is concentrated in particles its radiation only targets a small mass of tissue for an 
extended period of time. 
The   particles have also been shown to possess a specific action on DNA, and considerable 
chemical toxicity comes from the various chemical forms of uranium
15
 as well. As a crude 
approximation to the chemical damage to which the irradiated masses    and   are subjected, we 
may estimate the rate of unspecific bond breaking per cell  ̇  in the two compartments multiplying 
   by the factor            ⁄  and assuming                  
  , the O-H binding energy of 
water. Similarly, the number of broken chemical bonds   are obtained multiplying      by the 
same factor. For convenience, values of  ̇  are reported as functions of   and   in Table 8. From the 
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column ( ̇ )    in Table 1 we see that the rate of bond breaking per cell range from    
  to      
    for particles sized from     to       . It is worth stressing that it is immaterial whether the 
emitted   particles directly damage chemical bonds of biological significance or deliver their 
energy to water with formation of hydroxyl radicals HO
∙
 and H2O
∙+
 radical cations because these 
reactive species are able to rapidly diffuse to the regions of the cell containing the genetic material. 
 
 
CONCLUSION 
 
The limited range in tissue of alpha particles emitted by 
238
U considerably reduces the actual mass 
subjected to irradiation by ceramic particles of 
238
U3O8. Once this effect is taken into account in 
evaluating both the dose rate and the cumulative dose delivered to the affected tissues, 20 years 
after the exposure the averaged dose for               ranges from        to         for the 
lungs and from        to         for the lymph nodes. However, the body mass affected by the 
radiation is only a fraction of a gram and rapidly decreases with the third power of particle size. 
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Figure 1. Fraction of the initial mass of U3O8 distributing into the two compartments following 
intake versus time. 
 
 
 
 
Figure 2. Fraction of the number of particles     ⁄  in the two compartments versus time. 
 
 
 
 
  
   ⁄  
    ⁄  
    ⁄  
    ⁄  
   ⁄  
   ⁄  
    ⁄  
    ⁄  
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Figure 3. Plot of the dose rate     ⁄   
   delivered by U3O8 particles with         to the two 
compartments (     ) versus time.  
 
 
 
 
Figure 4. Plot of the dose     ⁄  and the averaged dose       ⁄  delivered by U3O8 particles 
with         to the two compartments (     ) versus time. 
 
 
 
  
   ⁄  
    ⁄   
   
   ⁄  
   
     
     
      ⁄  
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Table 1. Initial number of particles    of radius    in          of U3O8, the estimated number of 
affected cells, the initial dose rate, and the initial rate of bond breaking. 
 
    ⁄     cells       
  ⁄  ( ̇ )    
  ⁄  
0.4 6.95E+06 1.08E+07 1.28E-05 1.09E+03 
0.6 2.06E+06 3.20E+06 4.30E-05 3.68E+03 
0.8 8.68E+05 1.35E+06 1.02E-04 8.72E+03 
1.0 4.45E+05 6.92E+05 1.99E-04 1.70E+04 
1.2 2.57E+05 4.01E+05 3.44E-04 2.94E+04 
1.4 1.62E+05 2.52E+05 5.47E-04 4.67E+04 
1.6 1.09E+05 1.69E+05 8.16E-04 6.97E+04 
1.8 7.62E+04 1.19E+05 1.16E-03 9.93E+04 
2.0 5.56E+04 8.65E+04 1.59E-03 1.36E+05 
 
 
Table 2. Irradiated mass of the lungs    ⁄  following intake of          of U3O8 particles of initial 
radius    at various times after the exposure. 
 
    ⁄  1 yr 5 yr 10 yr 20 yr 
0.4 4.88E-01 8.46E-02 9.46E-03 1.18E-04 
0.6 1.45E-01 2.51E-02 2.80E-03 3.50E-05 
0.8 6.11E-02 1.06E-02 1.18E-03 1.48E-05 
1.0 3.13E-02 5.42E-03 6.05E-04 7.56E-06 
1.2 1.81E-02 3.13E-03 3.50E-04 4.37E-06 
1.4 1.14E-02 1.97E-03 2.21E-04 2.75E-06 
1.6 7.63E-03 1.32E-03 1.48E-04 1.85E-06 
1.8 5.36E-03 9.29E-04 1.04E-04 1.30E-06 
2.0 3.91E-03 6.77E-04 7.57E-05 9.45E-07 
 
 
Table 3. Irradiated mass in the lymph nodes    ⁄  following intake of          of U3O8 particles 
of initial radius    at various times after the exposure. 
 
    ⁄  1 yr 5 yr 10 yr 20 yr 
0.4 4.48E-02 1.12E-01 1.25E-01 1.26E-01 
0.6 1.33E-02 3.32E-02 3.69E-02 3.74E-02 
0.8 5.60E-03 1.40E-02 1.56E-02 1.58E-02 
1.0 2.87E-03 7.17E-03 7.97E-03 8.07E-03 
1.2 1.66E-03 4.15E-03 4.61E-03 4.67E-03 
1.4 1.04E-03 2.61E-03 2.91E-03 2.94E-03 
1.6 7.00E-04 1.75E-03 1.95E-03 1.97E-03 
1.8 4.91E-04 1.23E-03 1.37E-03 1.38E-03 
2.0 3.58E-04 8.97E-04 9.97E-04 1.01E-03 
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Table 4. Dose rate    (Gy d
-1
) delivered to a mass   of the lungs and lymph nodes upon intake of 
         of U3O8 particles of initial radius    at various times after the exposure. 
 
    ⁄  1 yr 5 yr 10 yr 20 yr 
0.4 4.84E-06 2.95E-06 1.58E-06 4.58E-07 
0.6 1.63E-05 9.95E-06 5.35E-06 1.54E-06 
0.8 3.87E-05 2.36E-05 1.27E-05 3.66E-06 
1.0 7.57E-05 4.61E-05 2.48E-05 7.15E-06 
1.2 1.31E-04 7.96E-05 4.28E-05 1.24E-05 
1.4 2.08E-04 1.26E-04 6.79E-05 1.96E-05 
1.6 3.10E-04 1.89E-04 1.01E-04 2.93E-05 
1.8 4.41E-04 2.69E-04 1.44E-04 4.17E-05 
2.0 6.05E-04 3.68E-04 1.98E-04 5.72E-05 
 
 
Table 5. Dose    (Gy) absorbed by a mass   of the lungs and lymph nodes upon intake of 
         of U3O8 particles of initial radius    at various times after the exposure. 
 
    ⁄  1 yr 5 yr 10 yr 20 yr 
0.4 1.99E-03 7.56E-03 1.16E-02 1.49E-02 
0.6 6.71E-03 2.55E-02 3.91E-02 5.02E-02 
0.8 1.59E-02 6.05E-02 9.26E-02 1.19E-01 
1.0 3.11E-02 1.18E-01 1.81E-01 2.33E-01 
1.2 5.37E-02 2.04E-01 3.13E-01 4.02E-01 
1.4 8.52E-02 3.24E-01 4.96E-01 6.38E-01 
1.6 1.27E-01 4.84E-01 7.41E-01 9.53E-01 
1.8 1.81E-01 6.89E-01 1.05E+00 1.36E+00 
2.0 2.48E-01 9.46E-01 1.45E+00 1.86E+00 
 
 
Table 6. Averaged dose       ⁄  absorbed by a mass    of the lungs upon intake of          
of U3O8 particles of initial radius    at various times after the exposure. 
 
    ⁄  1 yr 5 yr 10 yr 20 yr 
0.4 1.91E-03 5.83E-03 6.75E-03 6.83E-03 
0.6 6.46E-03 1.97E-02 2.28E-02 2.30E-02 
0.8 1.53E-02 4.67E-02 5.40E-02 5.46E-02 
1.0 2.99E-02 9.12E-02 1.05E-01 1.07E-01 
1.2 5.17E-02 1.58E-01 1.82E-01 1.84E-01 
1.4 8.20E-02 2.50E-01 2.89E-01 2.93E-01 
1.6 1.22E-01 3.73E-01 4.32E-01 4.37E-01 
1.8 1.74E-01 5.32E-01 6.15E-01 6.22E-01 
2.0 2.39E-01 7.29E-01 8.44E-01 8.53E-01 
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Table 7. Averaged dose       ⁄  absorbed by a mass    of the lymph nodes upon intake of 
         of U3O8 particles of initial radius    at various times after the exposure. 
 
    ⁄  1 yr 5 yr 10 yr 20 yr 
0.4 7.43E-05 1.73E-03 4.82E-03 8.06E-03 
0.6 2.51E-04 5.84E-03 1.63E-02 2.72E-02 
0.8 5.94E-04 1.38E-02 3.86E-02 6.45E-02 
1.0 1.16E-03 2.70E-02 7.54E-02 1.26E-01 
1.2 2.01E-03 4.67E-02 1.30E-01 2.18E-01 
1.4 3.19E-03 7.42E-02 2.07E-01 3.46E-01 
1.6 4.75E-03 1.11E-01 3.09E-01 5.16E-01 
1.8 6.77E-03 1.58E-01 4.40E-01 7.35E-01 
2.0 9.29E-03 2.16E-01 6.03E-01 1.01E+00 
 
 
Table 8. Rate of bond breaking per affected cell  ̇  
  ⁄  in the lungs and lymph nodes caused by 
the radiation delivered by          of U3O8 particles of initial radius    to the mass   of tissue at 
various times after the exposure. 
 
    ⁄  1 yr 5 yr 10 yr 20 yr 
0.4 4.14E+02 2.52E+02 1.35E+02 3.91E+01 
0.6 1.40E+03 8.50E+02 4.57E+02 1.32E+02 
0.8 3.31E+03 2.01E+03 1.08E+03 3.13E+02 
1.0 6.47E+03 3.93E+03 2.11E+03 6.11E+02 
1.2 1.12E+04 6.80E+03 3.65E+03 1.06E+03 
1.4 1.77E+04 1.08E+04 5.80E+03 1.68E+03 
1.6 2.65E+04 1.61E+04 8.66E+03 2.50E+03 
1.8 3.77E+04 2.29E+04 1.23E+04 3.56E+03 
2.0 5.17E+04 3.15E+04 1.69E+04 4.89E+03 
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